Spironolactone Therapy in Chronic Stable Right HF Trial

Summary

The purpose of this study is to evaluate the safety, tolerability and mechanistic effects of spironolactone, an aldosterone receptor antagonist, on sympathetic nervous system activity and right heart function and remodeling in patients with chronic right heart failure.

Timeline

Start

2018-04-01

Primary completion

2022-08-30

Completion

2024-05-01

Drugs

Indications